⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
globenewswire.com
HUMA
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
globenewswire.com
HUMA
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair
globenewswire.com
HUMA
Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
businesswire.com
HUMA
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
HUMA
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
globenewswire.com
HUMA
Humacyte Appoints Rick McElheny as Senior Vice President of Business Development
globenewswire.com
HUMA
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMA
HUMAW
Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia
globenewswire.com
HUMA